05-17-2024Cross-posted from: NIAID Now Vaccines consistently transform public health, and HIV vaccine research has been a pillar of NIAID’s scientific mission since the…
03-23-2022Cross-posted from NIAID NewsroomPhase 1 Study Is Among First to Examine mRNA Technology for HIVThe National Institute of Allergy and Infectious Diseases (NIAID…
12-15-2021Cross-posted from the NIAID NewsroomNIAID Scientists Developed Vaccine PlatformAn experimental HIV vaccine based on mRNA—the same platform technology used in…
03-09-2021In an HIV.gov video conversation yesterday, NIH’s Dr. Carl Dieffenbach shared highlights from HIV research presented at the 2021 virtual Conference on…
12-03-2020Cross-posted from NIAID NewsroomGrant Awards Set Stage for Next Seven Years of Science-Driven HIV Clinical ResearchThe National Institute of Allergy and…
09-15-2020Cross-posted from HHS Newsroom Summary: HHS is urging healthcare providers and parents to “catch-up to get ahead” on childhood immunizations. During National…
05-18-2020Cross-posted from NIAID NewsroomDecades of scientific advances have led to development and implementation of highly effective HIV treatment and prevention…
05-17-2019With this week’s observance of HIV Vaccine Awareness Day (HVAD – May 18), the HIV.gov team has been thinking about the important efforts to discover and test a…
10-24-2018Cross-posted from NIAID Now BlogA durable end to the HIV/AIDS pandemic will require the development and widespread implementation of new and improved HIV…
06-06-2018Cross-posted from NIH/NIAID NewsroomNIH Study Results Represent Major Advance for Structure-Based HIV Vaccine DesignAn experimental vaccine regimen based on…
11-08-2017Cross-posted from NIAID Newsroom Despite remarkable gains in the treatment and prevention of HIV infection, development of an effective HIV vaccine likely will…
07-24-2017Crossposted from NIAID Newsroom Results From Early-Stage NIH-Funded Trial Support Further Development of Candidate VaccinesResults from an early-stage clinical…
12-26-2016“What is PRO-140?” “In what phase of study is injectable cabotegravir?” “How do latency-reversing agents work?” Answers to all of these questions can be found…
12-02-2016In a Facebook Live interview from Cape Town, South Africa earlier this week, we heard from NIH’s Dr. Carl Dieffenbach about the exciting launch of HVTN 702, a…
11-29-2016Director’s Note, Office of HIV/AIDS and Infectious Disease Policy, HHS:Scientific advances have given us the tools we need to end new HIV infections and save…
11-28-2016South Africa Hosts Historic NIH-Supported Clinical Trial November 27, 2016The first HIV vaccine efficacy study to launch anywhere in seven years is now testing…
07-19-2016As the second day of the International AIDS Conference (AIDS 2016) came to a close in Durban, South Africa, we caught up with Dr. Carl Dieffenbach again via…
07-21-2015After the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) got underway in Vancouver, Canada yesterday, July…
05-18-2015May 18, 2015 Vaccination has historically been the best method for protecting against and ultimately defeating mankind’s most devastating infectious diseases…
05-19-2014Watch NIAID Director Anthony S. Fauci, M.D., discuss current HIV vaccine research approaches.Developing a safe and sufficiently effective HIV vaccine is…